Details of the Drug-Related molecule(s) Interaction Atlas
General Information of Drug (ID: DMGQC2F)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-(2-Pyrrolidinoethyl)Pyridine; 6311-90-6; CHEMBL270595; 2-[2-(Pyrrolidin-1-yl)ethyl]pyridine; N-(2-(2-pyridyl)ethyl)pyrrolidine; NSC42644; 2-[2-(1-Pyrrolidinyl)ethyl]pyridine; AC1Q4VNT; AC1L60PK; AC1Q28PR; SCHEMBL868571; 2-(2-Pyrrolizinoethyl)pyridine; CTK5B7636; DTXSID60285694; OXEFHEYEQUISKC-UHFFFAOYSA-N; ZINC393798; NSC-42644; 2-(2-pyrrolidin-1-ylethyl)pyridine; BDBM50372289; AKOS006243249; MCULE-8128571557; 2-(2-Pyrrolidin-1-yl-ethyl)-pyridine; Pyridine,2-[2-(1-pyrrolidinyl)ethyl]-; 2-[2-(1-Pyrrolidinyl)ethyl]pyridine #
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule-Related Drug Atlas
Molecule-Related Drug Atlas
Molecule Type:
DTT Drug Status:
Approved Drug(s) Clinical Trial Drug(s) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug(s) Targeting Histamine H3 receptor (H3R)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Molecular Interaction Atlas | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
References